Around two-thirds of women will develop at least one uterine fibroid in their lifetime, while one-third will be symptomatic. Black women are roughly two-to-three times more likely to develop UFs ...
Khaleelah I. L. Harris, a recent myomectomy patient and Yasmine Griffiths, a 4th year medical student at Howard University School of Medicine nonprofit 'The Beauty of Our Wellness.' ...
The patient was a follow-up case of subserosal fibroid uterus, chronic kidney disease stage 4 and rheumatic heart disease on anticoagulants. Fibroid degeneration or torsion was suspected. Ultrasound ...
Harris and Griffiths, recognizing the financial burden of fibroid treatment, founded The Beauty of Our Wellness, a Washington, D.C.-based nonprofit dedicated to providing financial assistance to ...
Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.
The majority of women with uterine fibroids are asymptomatic, consequently get less clinical attention and fibroid tumors often remain undiagnosed. [23,24] Symptomatic women typically complain ...